CDT Equity CDT
NASDAQ CDT
$1.36 -0.09 (-6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

CDT Equity (CDT) Notes Payables (2021 - 2024)

Updated

CDT Equity (CDT) reported Notes Payables of $800,000 for Q4 2024, up 332.4% from $185,000 a year earlier and up 578.0% from the prior quarter.

Analysis

CDT Equity (CDT) Notes Payables (2021 - 2024) Analysis & Trends

Dating back to Q4 2021, CDT Equity's Notes Payables record includes 9 quarters.

  • Notes Payables has a three-year compound annual growth rate of 65.3% (FY2021 to FY2024).
  • By year, Notes Payables came in at $185,000 in FY2023 (+5.7%), $175,000 in FY2022 (-1.2%) and $177,057 in FY2021.
  • The Q4 2024 figure ranks as the highest quarterly Notes Payables in data going back to Q4 2021.
  • Year over year, Notes Payables gained in two of the last four quarters, with growth averaging 66.5%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 CDT Equity 36,602.35 36,602.35 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 800,000.00
Sep 30, 2024 118,000.00
Mar 31, 2024 183,000.00
Dec 31, 2023 185,000.00
Sep 30, 2023 177,000.00
Jun 30, 2023 750,000.00
Mar 31, 2023 300,000.00
Dec 31, 2022 175,000.00
Dec 31, 2021 177,057.00
API Access

CDT Equity Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=CDT&period=max&api_key=YOUR_API_KEY